Billing and Coding: MolDX: Biomarkers in Cardiovascular Risk Assessment

This article (A57559) provides billing and coding guidance that complements the Local Coverage Determination MolDX: Biomarkers in Cardiovascular Risk Assessment (L36523). It does not define coverage or medical necessity; coverage and documentation requirements must be determined per LCD L36523 and any contractor-specific rules. For claims, follow the LCD's medical necessity, documentation, and submission requirements.

"This billing/coding article does not itself establish coverage or medical necessity; coverage decisions and clinical indications are determined by the Local Coverage Determination MolDX: Biomarkers..."

Sign up to see full coverage criteria, indications, and limitations.